These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 18066095

  • 1. Targeted cancer therapies based on the inhibition of DNA strand break repair.
    O'Connor MJ, Martin NM, Smith GC.
    Oncogene; 2007 Dec 10; 26(56):7816-24. PubMed ID: 18066095
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
    Bolderson E, Richard DJ, Zhou BB, Khanna KK.
    Clin Cancer Res; 2009 Oct 15; 15(20):6314-20. PubMed ID: 19808869
    [Abstract] [Full Text] [Related]

  • 3. New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response.
    Luo Y, Leverson JD.
    Expert Rev Anticancer Ther; 2005 Apr 15; 5(2):333-42. PubMed ID: 15877529
    [Abstract] [Full Text] [Related]

  • 4. Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.
    Lewis C, Low JA.
    Curr Opin Investig Drugs; 2007 Dec 15; 8(12):1051-6. PubMed ID: 18058575
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
    Ashwell S, Zabludoff S.
    Clin Cancer Res; 2008 Jul 01; 14(13):4032-7. PubMed ID: 18593978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DNA structure and integrity checkpoints during the cell cycle and their role in drug targeting and sensitivity of tumor cells to anticancer treatment.
    Skladanowski A, Bozko P, Sabisz M.
    Chem Rev; 2009 Jul 01; 109(7):2951-73. PubMed ID: 19522503
    [No Abstract] [Full Text] [Related]

  • 10. DNA repair pathways and their implication in cancer treatment.
    Pallis AG, Karamouzis MV.
    Cancer Metastasis Rev; 2010 Dec 01; 29(4):677-85. PubMed ID: 20821251
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemical strategies for development of ATR inhibitors.
    Llona-Minguez S, Höglund A, Jacques SA, Koolmeister T, Helleday T.
    Expert Rev Mol Med; 2014 May 09; 16():e10. PubMed ID: 24810715
    [Abstract] [Full Text] [Related]

  • 13. Twists and turns in the function of DNA damage signaling and repair proteins by post-translational modifications.
    Déry U, Masson JY.
    DNA Repair (Amst); 2007 May 01; 6(5):561-77. PubMed ID: 17258515
    [Abstract] [Full Text] [Related]

  • 14. Targeting DNA repair mechanisms in cancer.
    Furgason JM, Bahassi el M.
    Pharmacol Ther; 2013 Mar 01; 137(3):298-308. PubMed ID: 23107892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging cancer therapeutic opportunities target DNA-repair systems.
    Ding J, Miao ZH, Meng LH, Geng MY.
    Trends Pharmacol Sci; 2006 Jun 01; 27(6):338-44. PubMed ID: 16697054
    [Abstract] [Full Text] [Related]

  • 18. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
    Velic D, Couturier AM, Ferreira MT, Rodrigue A, Poirier GG, Fleury F, Masson JY.
    Biomolecules; 2015 Nov 20; 5(4):3204-59. PubMed ID: 26610585
    [Abstract] [Full Text] [Related]

  • 19. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.
    Aziz K, Nowsheen S, Georgakilas AG.
    Curr Mol Med; 2010 Oct 20; 10(7):626-39. PubMed ID: 20712589
    [Abstract] [Full Text] [Related]

  • 20. DNA topoisomerases in cancer chemotherapy: basic and applied aspects.
    Cortés F, Pastor N.
    Cytobios; 2001 Oct 20; 106 Suppl 2():217-27. PubMed ID: 11545448
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.